| Name | Title | Contact Details |
|---|---|---|
Ajim Tamboli |
Chief Financial Officer | Profile |
Devyn Smith |
Chief Executive Officer | Profile |
Megan Daley Woods |
Head of People and Community | Profile |
TYME is an emerging biotechnology company developing cancer therapeutics that are intended to be broadly effective across tumor types and have low toxicity profiles.
We build with carbon the same way nature does. Our biocement® materials are healthier for us and the Planet.
Surrozen is a biotechnology company focused on discovering and developing novel regenerative medicines with a focus on unlocking the powerful self-renewal properties of the body through specific control of the Wnt signaling pathway.
As a clinical-stage pharmaceutical company founded on cutting-edge research, ESSA is focused on developing novel therapeutics for cancer patients. ESSA embraces innovation not only in our products but also in our approach. We re firmly rooted in creative and open thinking, giving us an energy and approach that makes us a different kind of pharmaceutical company.
BioCryst Pharmaceuticals, Inc. is one of the leading companies in the Healthcare, Pharmaceuticals, and Biotech sector.